The biological significance of TIM3-related pathway in DLBCL was investigated based on RNA sequencing, immunohistochemistry, and reverse transcription-quantitative polymerase chain reaction data. The gene discussed is HAVCR2; the disease is diffuse large B-cell lymphoma.